UniChem 1st-Half Profits Rise 8%

10 September 1997

UniChem, the UK-based pharmaceuticals group, has announced an 8% rise inpre-tax profits to L26.9 million ($42.6 million) for the six months ended June 30, 1997. Sales rose 16% to L832.9 million, bolstered by the consolidation of the group's joint wholesaling venture in Portugal.

Encouraged by its results, UniChem claims that its sales are growing faster than at German rival Gehe, which won the L684 million bid battle for Lloyds Chemists (Marketletters passim).

Unichem's wholesale business sales rose 8% in the six months to June, while Gehe's UK sales for the same period only rose 3%. As well as wresting the contract away from the German group to supply Superdrug's 120 pharmacies, the group's 6.6% retail gain outstripped the 3% rise at Gehe.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight